medigraphic.com

2005, Number 3

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2005; 43 (3)

Body Fat Distribution in Patients with Type 2 Diabetes as a Cardiovascular Risk Factor

Ríos OLM, Legorreta SJ

Language: Spanish
References: 53
Page: 199-204
PDF size: 77.44 Kb.


ABSTRACT

Objective: Our objective was to compare body fat distribution in subjects with type 2 diabetes by indexes of the waist-hip, waist-height, and body mass indices, as well as its association with cardiovascular disease.
Materials and methods: We conducted a com-parative cross-sectional study with 1,144 persons ›30 years of age with type 2 diabetes at their assigned unit during the period of December 1996 through February 1997. We carried out meas-urement standardization and a pilot test. Studied variables included sex, age, sedentary lifestyle, smoking, time of diagnosis of diabetes, high blood pressure, cardiovascular disease, and obesity.
Results: Of the studied population, 81% were ›50 years of age, 63% were women; 47% were sedentary, 41% had smoking antecedent, 45% had high blood pressure, and an equal number of persons had a diagnosis of diabetes during the previous 10 years; 13% had some cardiovascular disease. Prevalence of obesity and the cardio-vascular risk detected changed in each of the following indices: body mass 72% and 1.3; waist-hip 81% and 1.6, and waist-height, 93.7% and 3.0.
Conclusion: Body fat distribution measured by waist indices detected more prevalence of obesity and cardiovascular risk than body mass index, which does not consider the waist measurement.


REFERENCES

  1. Secretaría de Salud. Norma oficial mexicana NOM-174-SSA-1998, para el manejo integral de la obesidad. Diario Oficial de la Federación, 7 de diciembre de 1998.

  2. Zárate A, Basurto-Acevedo L, Saucedo-García RP. La obesidad: conceptos actuales sobre fisiopatogenia y tratamiento. Rev Fac Med UNAM 2001;44(2):66-70.

  3. Zimmet P, Thomas CR. Genotype, obesity and cardiovascular disease–has technical and social advancement outstripped evolution? J Intern Med 2003;254(2):114-125.

  4. González-Villalpando G, Stern MP. La obesidad como factor de riesgo cardiovascular en México. Estudio en población abierta. Rev Invest Clin 1993;45(1):13-21.

  5. Gray DS. Diagnosis and prevalence of obesity. Med Clin N Am 1989;73:1-10.

  6. Pi-Sunyer FX. Obesidad: causas de morbimortalidad. Clin Rev 1994;1(1):15-18.

  7. Yáñez M, Albala C. Distribución de grasa corporal: indicadores antropométricos. Rev Med Chil 1995;123(5): 1520-1524.

  8. Oria E, Lafita J, Petrina E, Arguelles I. Composición corporal y obesidad. Ana Sis San Navarra 2002;25(1):91-

  9. Secretaría de Salud. Encuesta Nacional de Salud II. México: Dirección General de Epidemiología, SSA; 1994.

  10. Velásquez-Monroy O, Rosas-Peralta M, Lara-Esqueda A, Pastelín-Hernández G, Grupo ENSA 2000, Sánchez-Castillo C, et al. Prevalencia e interrelación de enfermedades crónicas no transmisibles y factores de riesgo cardiovascular en México: resultados finales de la Encuesta Nacional de Salud (ENSA) 2000. Arch Inst Cardiol Mex 2003;73(1):62-77.

  11. Heras MR, Macías GR, Araíz del Rosario R. Diabetes mellitus: complicaciones crónicas y factores de riesgo. Rev Med IMSS 1996;34(6):449-455.

  12. Dean AG, Dean JA, Burton A, Dicker R. Epi Info, versión 5. Epidemiología con microordenadores. Ginebra, Suiza: WHO; 1992.

  13. Pouliot MC, Despres JP, Lemieux S. Waist circumference and abdominal saggital diameter: best simple anthropometric indexes of abdominal visceral adipose

  14. tissue acumulation and related cardiovascular risk in men and women. Am J Cardiol 1994;73(7):460-468.

  15. Solorio S, Badui E, Yañes MA. Distribución de grasa corporal como factor de riesgo coronario. Rev Med IMSS 1996;34(6):445-448.

  16. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000;21(6):697-738.

  17. Corona MI, Camacho HR, Escobedo PJ. Obesidad, distribución de la grasa corporal y cardiopatía isquémica en población mexicana. Arch Inst Cardiol Mex 1996;

  18. 66(2):143-150.

  19. Quibrera IR, Hernández-Rodríguez HG, Aradillas GC, González-Rodríguez S, Calles EJ. Prevalencia de diabetes, intolerancia a la glucosa, hiperlipemia y factores

  20. de riesgo en función de nivel socioeconómico. Rev Invest Clin 1994;46(1):25-36.

  21. Graupner C, Rodríguez-Padial L, García de Castro A. Síndrome metabólico e hipertensión. Monocardio 2003;5(3):167-176.

  22. Erbey JR, Kuller LH, Becker DJ, Orchard TJ. The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes

  23. population. Diabetes Care 1998;22(7):1084-1091.

  24. Hsieh SD, Yoshinaga H. Abdominal fat distribution and coronary heart disease risk factors in men-waist/height ratio as a simple and useful predictor. Int J

  25. Obes Relat Metab Disord 1995;19(6):585-589.

  26. Hsieh SD, Yoshinaga H. Is there any difference in coronary heart disease risk factors and prevalence of fatty liver in subjects with normal body mass index

  27. having different techniques? Tohoku J Exp Med 1995; 177(4):223-231.

  28. Hsie SD, Yoshinaga H, Muto T. Waist to height ratio, and simple and practical index for assessing central fat distribution and metabolic risk in Japanese men

  29. and women. Int J Obesity 2003;27(6):610-616.

  30. Li G, Chen X, Jang Y, et al. Obesity, coronary heart disease risk factors and diabetes in Chinese: an approach to the criteria of obesity in the Chinese population. Obes Rev 2002;3(3):167-172.

  31. Secretaría de Salud. Norma oficial mexicana NOM-174-SSA-1998, para el manejo integral de la obesidad. Diario Oficial de la Federación, 7 de diciembre de 1998.

  32. Zárate A, Basurto-Acevedo L, Saucedo-García RP. La obesidad: conceptos actuales sobre fisiopatogenia y tratamiento. Rev Fac Med UNAM 2001;44(2):66-70.

  33. Zimmet P, Thomas CR. Genotype, obesity and cardiovascular disease–has technical and social advancement outstripped evolution? J Intern Med 2003;254(2):114-125.

  34. González-Villalpando G, Stern MP. La obesidad como factor de riesgo cardiovascular en México. Estudio en población abierta. Rev Invest Clin 1993;45(1):13-21.

  35. Gray DS. Diagnosis and prevalence of obesity. Med Clin N Am 1989;73:1-10.

  36. Pi-Sunyer FX. Obesidad: causas de morbimortalidad. Clin Rev 1994;1(1):15-18.

  37. Yáñez M, Albala C. Distribución de grasa corporal: indicadores antropométricos. Rev Med Chil 1995;123(5): 1520-1524.

  38. Oria E, Lafita J, Petrina E, Arguelles I. Composición corporal y obesidad. Ana Sis San Navarra 2002;25(1):91-

  39. Secretaría de Salud. Encuesta Nacional de Salud II. México: Dirección General de Epidemiología, SSA; 1994.

  40. Velásquez-Monroy O, Rosas-Peralta M, Lara-Esqueda A, Pastelín-Hernández G, Grupo ENSA 2000, Sánchez-Castillo C, et al. Prevalencia e interrelación de enfermedades crónicas no transmisibles y factores de riesgo cardiovascular en México: resultados finales de la Encuesta Nacional de Salud (ENSA) 2000. Arch Inst Cardiol Mex 2003;73(1):62-77.

  41. Heras MR, Macías GR, Araíz del Rosario R. Diabetes mellitus: complicaciones crónicas y factores de riesgo. Rev Med IMSS 1996;34(6):449-455.

  42. Dean AG, Dean JA, Burton A, Dicker R. Epi Info, versión 5. Epidemiología con microordenadores. Ginebra, Suiza: WHO; 1992.

  43. Pouliot MC, Despres JP, Lemieux S. Waist circumference and abdominal saggital diameter: best simple anthropometric indexes of abdominal visceral adipose tissue acumulation and related cardiovascular risk in men and women. Am J Cardiol 1994;73(7):460-468.

  44. Solorio S, Badui E, Yañes MA. Distribución de grasa corporal como factor de riesgo coronario. Rev Med IMSS 1996;34(6):445-448.

  45. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000;21(6):697-738.

  46. Corona MI, Camacho HR, Escobedo PJ. Obesidad, distribución de la grasa corporal y cardiopatía isquémica en población mexicana. Arch Inst Cardiol Mex 1996; 66(2):143-150.

  47. Quibrera IR, Hernández-Rodríguez HG, Aradillas GC, González-Rodríguez S, Calles EJ. Prevalencia de diabetes, intolerancia a la glucosa, hiperlipemia y factores de riesgo en función de nivel socioeconómico. Rev Invest Clin 1994;46(1):25-36.

  48. Graupner C, Rodríguez-Padial L, García de Castro A. Síndrome metabólico e hipertensión. Monocardio 2003;5(3):167-176.

  49. Erbey JR, Kuller LH, Becker DJ, Orchard TJ. The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes population. Diabetes Care 1998;22(7):1084-1091.

  50. Hsieh SD, Yoshinaga H. Abdominal fat distribution and coronary heart disease risk factors in men-waist/height ratio as a simple and useful predictor. Int J Obes Relat Metab Disord 1995;19(6):585-589.

  51. Hsieh SD, Yoshinaga H. Is there any difference in coronary heart disease risk factors and prevalence of fatty liver in subjects with normal body mass index having different techniques? Tohoku J Exp Med 1995; 177(4):223-231.

  52. Hsie SD, Yoshinaga H, Muto T. Waist to height ratio, and simple and practical index for assessing central fat distribution and metabolic risk in Japanese men and women. Int J Obesity 2003;27(6):610-616.

  53. Li G, Chen X, Jang Y, et al. Obesity, coronary heart disease risk factors and diabetes in Chinese: an approach to the criteria of obesity in the Chinese population. Obes Rev 2002;3(3):167-172.




2020     |     www.medigraphic.com